Recent advances in shell-sheddable nanoparticles for cancer therapy

Journal of Biomedical Nanotechnology

Volumn 10, Issue 9, 2014, Pages 1841-1862

  Thambi, Thavasyappan ^a   Park, Jae Hyung ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Micelle; pH; Polymeric nanoparticles; Reducing agents; Triggered release

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; DISEASES; DRUG DELIVERY; DRUG PRODUCTS; MICELLES; ONCOLOGY; PH; POLYMERS; REDUCING AGENTS; SHELLS (STRUCTURES); TUMORS;

ANTI-TUMOR EFFICACY; DRAINAGE SYSTEMS; ENHANCED PERMEATION AND RETENTIONS; INCURABLE DISEASE; PASSIVE DIFFUSIONS; POLYMERIC NANOPARTICLES; SYSTEMIC ADMINISTRATION; TRIGGERED RELEASE;

NANOPARTICLES;

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FIRTECAN; IRINOTECAN; LIPOSOME; NANOCARRIER; NANOPARTICLE; PACLITAXEL; POLYMER; ENZYME;

ANTINEOPLASTIC ACTIVITY; BIOCOMPATIBILITY; CANCER THERAPY; DRUG DELIVERY SYSTEM; DRUG TOLERANCE; HUMAN; LYMPHATIC DRAINAGE; MICELLE; NONHUMAN; OXIDATION REDUCTION REACTION; PH; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POLYMERIZATION; REVIEW; TUMOR MICROENVIRONMENT; ANIMAL; CHEMISTRY; METABOLISM; NEOPLASMS;

ANIMALS; DRUG DELIVERY SYSTEMS; ENZYMES; HUMANS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; NEOPLASMS; POLYMERS;

EID: 84904888067     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1977     Document Type: Review

References (221)

1. B. A. Chabner and T. G. Roberts, Chemotherapy and the war on cancer. Nat. Rev. Cancer 5, 65 (2005).
2. K. Strebhardt and A. Ullrich, Paul Ehrlich's magic bullet concept: 100 years of progress. Nat. Rev. Cancer 8, 473 (2008).
3. R. Duncan, Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer 6, 688 (2006).
4. M. Ferrari, Cancer nanotechnology: Opportunities and challenges. Nat. Rev. Cancer 5, 161 (2005).
5. D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751 (2007).
6. H. Cabral, Y. Matsumoto, K. Mizuno, Q. Chen, M. Murakami, M. Kimura, Y. Terada, M. R. Kano, K. Miyazono, M. Uesaka, N. Nishiyama, and K. Kataoka, Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol. 6, 815 (2011).
7. R. Duncan, The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2, 347 (2003).
8. D. A. LaVan, T. McGuire, and R. Langer, Small-scale systems for in vivo drug delivery. Nat. Biotechnol. 21, 11Q84 (2003).
9. M. Sivasubramanian, T. Thambi, and J. H. Park, Mineralized cyclodextrin nanoparticles for sustained protein delivery. Carbohydr. Polym. 97, 643 (2013).
10. J. Singh, W. Mohammed-Saied, R. Kaur, and I. Badea, Nanoparticles in gene therapy: From design to clinical applications. Rev. Nanosci. Nanotechnol. 2, 275 (2013).
11. R. Misra, M. Upadhyay, and S. Mohanty, Nanoparticles as carriers for chemotherapeutic drugs: A review. J. Nanopharm. Drug Delivery 1, 103 (2013).
12. Q. Yang, J. Liao, X. Deng, J. Liang, C. Long, C. Xie, X. Chen, L. Zhang, J. Sun, J. Peng, B. Chu, G. Guo, F. Luo, and Z. Qian, Anti-tumor activity and safety evaluation of fisetin-loaded methoxy poly(ethylene glycol)-Poly(ε- caprolactone) nanoparticles. J. Biomed. Nanotechnol. 10, 580 (2014).
13. J. M. Harris and R. B. Chess, Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov. 2, 214 (2003).
14. A. Rösler, G. W. M. Vandermeulen, and H.-A. Klok, Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv. Drug Deliv. Rev. 53, 95 (2001).
15. V. P. Torchilin, Micellar nanocarriers: Pharmaceutical perspectives. Pharm. Res. 24, 1 (2007).
16. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J. Control Release 65, 271 (2000).
17. H. Maeda, The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41, 189 (2001).
18. Y. Matsumura and H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387 (1986).
19. K. H. Min, H. J. Lee, K. Kim, I. C. Kwon, S. Y. Jeong, and S. C. Lee, The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. Biomaterials 33, 5788 (2012).
20. S. Jang, M. G. Wientjes, D. Lu, and J. S. Au, Drug delivery and transport to solid tumors. Pharm. Res. 20, 1337 (2003).
21. S. K. Hobbs, W. L. Monsky, F. Yuan, W. G. Roberts, L. Griffith, V. P. Torchilin, and R. K. Jain, Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc. Natl. Acad. Sci. 95, 4607 (1998).
22. J.-P. Jee, J. H. Na, S. Lee, S. H. Kim, K. Choi, Y. Yeo, and I. C. Kwon, Cancer targeting strategies in nanomedicine: Design and application of chitosan nanoparticles. Curr. Opin. Solid St. M. 16, 333 (2012).
23. K. Osada, R. J. Christie, and K. Kataoka, Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery. J. R. Soc. Interface 6, S325-S339 (2009).
24. J.-H. Ryu, S. Bickerton, J. Zhuang, and S. Thayumanavan, Liganddecorated nanogels: Fast one-pot synthesis and cellular targeting. Biomacromolecules 13, 1515 (2012).
25. S. Zitzmann, V. Ehemann, and M. Schwab, Arginine-glycineaspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. Cancer Res. 62, 5139 (2002).
26. S.-H. Kim, J.-H. Kim, D. G. You, G. Saravanakumar, H. Y. Yoon, K. Y. Choi, T. Thambi, V. G. Deepagan, D.-G. Jo, and J. H. Park, Self-assembled dextran sulphate nanoparticles for targeting rheumatoid arthritis. Chem. Commun. 49, 10349 (2013).
27. K. Y. Choi, H. Y. Yoon, J.-H. Kim, S. M. Bae, R.-W. Park, Y. M. Kang, I.-S. Kim, I. C. Kwon, K. Choi, S. Y. Jeong, K. Kim, and J. H. Park, Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano 5, 8591 (2011).
28. T. M. Allen and P. R. Cullis, Drug delivery systems: Entering the mainstream. Science 303, 1818 (2004).
29. S. Egusquiaguirre, M. Igartua, R. Hernández, and J. Pedraz, Nanoparticle delivery systems for cancer therapy: Advances in clinical and preclinical research. Clin. Transl. Oncol. 14, 83 (2012).
30. D. W. Northfelt, B. J. Dezube, J. A. Thommes, B. J. Miller, M. A. Fischl, A. Friedman-Kien, L. D. Kaplan, C. Du Mond, R. D. Mamelok, and D. H. Henry, Pegylated-liposomal doxorubicin versus dxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's Sarcoma: Results of a randomized Phase III clinical trial. J. Clin. Oncol. 16, 2445 (1998).
31. F. Muggia and A. Hamilton, Phase III data on Caelyx® in ovarian cancer. Eur. J. Cancer 37, 15 (2001).
32. G. Batist, G. Ramakrishnan, C. S. Rao, A. Chandrasekharan, J. Gutheil, T. Guthrie, P. Shah, A. Khojasteh, M. K. Nair, K. Hoelzer, K. Tkaczuk, Y. C. Park, L. W. Lee, and F. T. M. S. Group, Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. J. Clin. Oncol. 19, 1444 (2001).
33. H. Ishii, J. Furuse, M. Nagase, Y. Maru, M. Yoshino, and T. Hayashi, A Phase I study of hepatic arterial infusion chemotherapy with zinostatin stimalamer alone for hepatocellular carcinoma. Jpn. J. Clin. Oncol. 33, 570 (2003).
34. T.-Y. Kim, D.-W. Kim, J.-Y. Chung, S. G. Shin, S.-C. Kim, D. S. Heo, N. K. Kim, and Y.-J. Bang, Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin. Cancer Res. 10, 3708 (2004).
35. T. Hamaguchi, T. Doi, T. Eguchi-Nakajima, K. Kato, Y. Yamada, Y. Shimada, N. Fuse, A. Ohtsu, S.-I. Matsumoto, M. Takanashi, and Y. Matsumura, Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors. Clin. Cancer Res. 16, 5058 (2010).
36. Y. Matsumura, T. Hamaguchi, T. Ura, K. Muro, Y. Yamada, Y. Shimada, K. Shirao, T. Okusaka, H. Ueno, M. Ikeda, and N. Watanabe, Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br. J. Cancer 91, 1775 (2004).
37. K. Kato, K. Chin, T. Yoshikawa, K. Yamaguchi, Y. Tsuji, T. Esaki, K. Sakai, M. Kimura, T. Hamaguchi, Y. Shimada, Y. Matsumura, and R. Ikeda, Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer. Invest. New Drugs 30, 1621 (2012).
38. R. Plummer, R. H. Wilson, H. Calvert, A. V. Boddy, M. Griffin, J. Sludden, M. J. Tilby, M. Eatock, D. G. Pearson, C. J. Ottley, Y. Matsumura, K. Kataoka, and T. Nishiya, A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. Br. J. Cancer 104, 593 (2011).
39. Y. Machida, H. Onishi, A. Kurita, H. Hata, A. Morikawa, and Y. Machida, Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats. J. Control Release 66, 159 (2000).
40. T. Musumeci, C. A. Ventura, I. Giannone, B. Ruozi, L. Montenegro, R. Pignatello, and G. Puglisi, PLA/PLGA nanoparticles for sustained release of docetaxel. Int. J. Pharm. 325, 172 (2006).
41. X. Shuai, H. Ai, N. Nasongkla, S. Kim, and J. Gao, Micellar carriers based on block copolymers of poly([var epsilon]-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J. Control Release 98, 415 (2004).
42. S. Mura, J. Nicolas, and P. Couvreur, Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12, 991 (2013).
43. H. Wei, R.-X. Zhuo, and X.-Z. Zhang, Design and development of polymeric micelles with cleavable links for intracellular drug delivery. Prog. Polym. Sci. 38, 503 (2013).
44. Y. Li, G. H. Gao, and D. S. Lee, Stimulus-sensitive polymeric nanoparticles and their applications as drug and gene carriers. Adv. Healthcare Mater. 2, 388 (2013).
45. K. Sampathkumar, S. Arulkumar, and M. Ramalingam, Advances in stimuli responsive nanobiomaterials for cancer therapy. J. Biomed. Nanotechnol. 10, 367 (2014).
46. F. Zhan, W. Chen, Z. Wang, W. Lu, R. Cheng, C. Deng, F. Meng, H. Liu, and Z. Zhong, Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release. Biomacromolecules 12, 3612 (2011).
47. Y. Li, K. Xiao, J. Luo, W. Xiao, J. S. Lee, A. M. Gonik, J. Kato, T. A. Dong, and K. S. Lam, Well-defined, reversible disulfide crosslinked micelles for on-demand paclitaxel delivery. Biomaterials 32, 6633 (2011).
48. T. Thambi, V. G. Deepagan, H. Y. Yoon, H. S. Han, S.-H. Kim, S. Son, D.-G. Jo, C.-H. Ahn, Y. D. Suh, K. Kim, I. Chan Kwon, D. S. Lee, and J. H. Park, Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery. Biomaterials 35, 1735 (2014).
49. T.-Y. Liu, K.-H. Liu, D.-M. Liu, S.-Y. Chen, and I. W. Chen, Temperature-sensitive nanocapsules for controlled drug release caused by magnetically triggered structural disruption. Adv. Funct. Mater. 19, 616 (2009).
50. G. Liu, W. Liu, and C.-M. Dong, UV- and NIR-responsive polymeric nanomedicines for on-demand drug delivery. Polym. Chem. 4, 3431 (2013).
51. R. de la Rica, D. Aili, and M. M. Stevens, Enzyme-responsive nanoparticles for drug release and diagnostics. Adv. Drug Deliv. Rev. 64, 967 (2012).
52. J.-Z. Du, X.-J. Du, C.-Q. Mao, and J. Wang, Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. J. Am. Chem. Soc. 133, 17560 (2011).
53. T. Waku, M. Matsumoto, M. Matsusaki, and M. Akashi, Complete surface control of peptide nanospheres with detachable and attachable polymer brush layers. Chem. Commun. 46, 7025 (2010).
54. K. Y. Choi, K. H. Min, H. Y. Yoon, K. Kim, J. H. Park, I. C. Kwon, K. Choi, and S. Y. Jeong, PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials 32, 1880 (2011).
55. R. Gref, M. Lück, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blunk, and R. H. Müller, 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf., B 18, 301 (2000).
56. Z. Amoozgar and Y. Yeo, Recent advances in stealth coating of nanoparticle drug delivery systems. Rev. Nanomed. Nanobiotechnol. 4, 219 (2012).
57. G. Storm, S. O. Belliot, T. Daemen, and D. D. Lasic, Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv. Drug Deliv. Rev. 17, 31 (1995).
58. B. Romberg, W. Hennink, and G. Storm, Sheddable coatings for long-circulating nanoparticles. Pharm. Res. 25, 55 (2008).
59. F. Meng, W. E. Hennink, and Z. Zhong, Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials 30, 2180 (2009).
60. R. Cheng, F. Feng, F. Meng, C. Deng, J. Feijen, and Z. Zhong, Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J. Control Release 152, 2 (2011).
61. M. Huo, J. Yuan, L. Tao, and Y. Wei, Redox-responsive polymers for drug delivery: From molecular design to applications. Polym. Chem. 5, 1519 (2014).
62. E. Fleige, M. A. Quadir, and R. Haag, Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications. Adv. Drug Deliv. Rev. 64, 866 (2012).
63. B. K. Sourkohi, A. Cunningham, Q. Zhang, and J. K. Oh, Biodegradable block copolymer micelles with thiol-responsive sheddable coronas. Biomacromolecules 12, 3819 (2011).
64. F. Meng, R. Cheng, C. Deng, and Z. Zhong, Intracellular drug release nanosystems. Mater. Today 15, 436 (2012).
65. H. Sun, F. Meng, R. Cheng, C. Deng, and Z. Zhong, Reduction-sensitive degradable micellar nanoparticles as smart and intuitive delivery systems for cancer chemotherapy. Expet. Opin. Drug Deliv. 10, 1109 (2013).
66. C. Deng, Y. Jiang, R. Cheng, F. Meng, and Z. Zhong, Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: Promises, progress and prospects. Nano Today 7, 467 (2012).
67. Y.-M. Go and D. P. Jones, Redox compartmentalization in eukaryotic cells. Biochim. Biophys. Acta 1780, 1273 (2008).
68. G. Wu, Y.-Z. Fang, S. Yang, J. R. Lupton, and N. D. Turner, Glutathione metabolism and its implications for health. J. Nutr. 134, 489 (2004).
69. D. P. Jones, J. L. Carlson, P. S. Samiec, P. Sternberg, V. C. Mody, R. L. Reed, and L. A. S. Brown, Glutathione measurement in human plasma: Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin. Chim. Acta 275, 175 (1998).
70. L.-Y. Tang, Y.-C. Wang, Y. Li, J.-Z. Du, and J. Wang, Shell-detachable micelles based on disulfide-linked block copolymer as potential carrier for intracellular drug delivery. Bioconjugate Chem. 20, 1095 (2009).
71. Y.-C. Wang, F. Wang, T.-M. Sun, and J. Wang, Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells. Bioconjugate Chem. 22, 1939 (2011).
72. H. Sun, B. Guo, R. Cheng, F. Meng, H. Liu, and Z. Zhong, Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials 30, 6358 (2009).
73. H. Sun, B. Guo, X. Li, R. Cheng, F. Meng, H. Liu, and Z. Zhong, Shell-sheddable micelles based on dextran-SS-poly(ε-caprolactone) diblock copolymer for efficient intracellular release of doxorubicin. Biomacromolecules 11, 848 (2010).
74. T. Thambi, H. Y. Yoon, K. Kim, I. C. Kwon, C. K. Yoo, and J. H. Park, Bioreducible block copolymers based on poly(ethylene glycol) and poly(γ-Benzyl l-glutamate) for intracellular delivery of camptothecin. Bioconjugate Chem. 22, 1924 (2011).
75. T. Thambi, G. Saravanakumar, J.-U. Chu, R. Heo, H. Ko, V. Deepagan, J.-H. Kim, and J. Park, Synthesis and physicochemical characterization of reduction-sensitive block copolymer for intracellular delivery of doxorubicin. Macromol. Res. 21, 100 (2013).
76. Q. Guo, P. Luo, Y. Luo, F. Du, W. Lu, S. Liu, J. Huang, and J. Yu, Fabrication of biodegradable micelles with sheddable poly(ethylene glycol) shells as the carrier of 7-ethyl-10-hydroxy-camptothecin. Colloids Surf., B 100, 138 (2012).
77. H.-Y. Wen, H.-Q. Dong, W.-j. Xie, Y.-Y. Li, K. Wang, G. M. Pauletti, and D.-L. Shi, Rapidly disassembling nanomicelles with disulfide-linked PEG shells for glutathione-mediated intracellular drug delivery. Chem. Commun. 47, 3550 (2011).
78. T.-B. Ren, W.-J. Xia, H.-Q. Dong, and Y.-Y. Li, Sheddable micelles based on disulfide-linked hybrid PEG-polypeptide copolymer for intracellular drug delivery. Polymer 52, 3580 (2011).
79. N. Song, W. Liu, Q. Tu, R. Liu, Y. Zhang, and J. Wang, Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery. Colloids Surf., B 87, 454 (2011).
80. T.-B. Ren, Y. Feng, Z.-H. Zhang, L. Li, and Y.-Y. Li, Shell-sheddable micelles based on star-shaped poly(ε-caprolactone)-SS-poly (ethyl glycol) copolymer for intracellular drug release. Soft Matter 7, 2329 (2011).
81. A. N. Koo, H. J. Lee, S. E. Kim, J. H. Chang, C. Park, C. Kim, J. H. Park, and S. C. Lee, Disulfide-cross-linked PEG-poly(amino acid)s copolymer micelles for glutathione-mediated intracellular drug delivery. Chem. Commun. 48, 6570 (2008).
82. A. N. Koo, K. H. Min, H. J. Lee, S.-U. Lee, K. Kim, I. Chan Kwon, S. H. Cho, S. Y. Jeong, and S. C. Lee, Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links. Biomaterials 33, 1489 (2012).
83. W. Chen, P. Zhong, F. Meng, R. Cheng, C. Deng, J. Feijen, and Z. Zhong, Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release. J. Control Release 169, 171 (2013).
84. W. Wang, H. Sun, F. Meng, S. Ma, H. Liu, and Z. Zhong, Precise control of intracellular drug release and anti-tumor activity of biodegradable micellar drugs via reduction-sensitive shell-shedding. Soft Matter 8, 3949 (2012).
85. X.-Q. Li, H.-Y. Wen, H.-Q. Dong, W.-M. Xue, G. M. Pauletti, X.-J. Cai, W.-J. Xia, D. Shi, and Y.-Y. Li, Self-assembling nanomicelles of a novel camptothecin prodrug engineered with a redoxresponsive release mechanism. Chem. Commun. 47, 8647 (2011).
86. M. Watanabe, K. Kawano, M. Yokoyama, P. Opanasopit, T. Okano, and Y. Maitani, Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability. Int. J. Pharm. 308, 183 (2006).
87. Y. Li, R. Tong, H. Xia, H. Zhang, and J. Xuan, High intensity focused ultrasound and redox dual responsive polymer micelles. Chem. Commun. 46, 7739 (2010).
88. H. A. Skinner, A revision of some bond-energy values and the variation of bond-energy with bond-length. Trans. Faraday Soc. 41, 645 (1945).
89. I. Park, S. S. Sheiko, A. Nese, and K. Matyjaszewski, Molecular tensile testing machines: Breaking a specific covalent bond by adsorption-induced tension in brushlike macromolecules. Macromolecules 42, 1805 (2009).
90. S. Kwon, J. H. Park, H. Chung, I. C. Kwon, S. Y. Jeong, and I.-S. Kim, Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5β-cholanic acid. Langmuir 19, 10188 (2003).
91. N. Ma, Y. Li, H. Xu, Z. Wang, and X. Zhang, Dual redox responsive assemblies formed from diselenide block copolymers. J. Am. Chem. Soc. 132, 442 (2009).
92. P. Han, N. Ma, H. Ren, H. Xu, Z. Li, Z. Wang, and X. Zhang, Oxidation-responsive micelles based on a selenium-containing polymeric superamphiphile. Langmuir 26, 14414 (2010).
93. N. Ma, H. Xu, L. An, J. Li, Z. Sun, and X. Zhang, Radiation-sensitive diselenide block co-polymer micellar aggregates: Toward the combination of radiotherapy and chemotherapy. Langmuir 27, 5874 (2011).
94. Y. Sun, X. Yan, T. Yuan, J. Liang, Y. Fan, Z. Gu, and X. Zhang, Disassemblable micelles based on reduction-degradable amphiphilic graft copolymers for intracellular delivery of doxorubicin. Biomaterials 31, 7124 (2010).
95. Q. Zhang, N. Re Ko, and J. K. Oh, Recent advances in stimuliresponsive degradable block copolymer micelles: Synthesis and controlled drug delivery applications. Chem. Commun. 48, 7542 (2012).
96. N. Chan, S. Y. An, and J. K. Oh, Dual location disulfide degradable interlayer-crosslinked micelles with extended sheddable coronas exhibiting enhanced colloidal stability and rapid release. Polym. Chem. 5, 1637 (2014).
97. Q. Zhang, S. Aleksanian, S. M. Noh, and J. K. Oh, Thiol-responsive block copolymer nanocarriers exhibiting tunable release with morphology changes. Polym. Chem. 4, 351 (2013).
98. A. Nelson-Mendez, S. Aleksanian, M. Oh, H.-S. Lim, and J. K. Oh, Reductively degradable polyester-based block copolymers prepared by facile polycondensation and ATRP: Synthesis, degradation, and aqueous micellization. Soft Matter. 7, 7441 (2011).
99. N. Chan, B. Khorsand, S. Aleksanian, and J. K. Oh, A dual location stimuli-responsive degradation strategy of block copolymer nanocarriers for accelerated release. Chem. Commun. 49, 7534 (2013).
100. B. Khorsand, G. Lapointe, C. Brett, and J. K. Oh, Intracellular drug delivery nanocarriers of glutathione-responsive degradable block copolymers having pendant disulfide linkages. Biomacromolecules 14, 2103 (2013).
101. S. Aleksanian, B. Khorsand, R. Schmidt, and J. K. Oh, Rapidly thiol-responsive degradable block copolymer nanocarriers with facile bioconjugation. Polym. Chem. 3, 2138 (2012).
102. J. Chen, X. Qiu, J. Ouyang, J. Kong, W. Zhong, and M. M. Q. Xing, pH and reduction dual-sensitive copolymeric micelles for intracellular doxorubicin delivery. Biomacromolecules 12, 3601 (2011).
103. I.-h. Oh, H. S. Min, L. Li, T. H. Tran, Y.-k. Lee, I. C. Kwon, K. Choi, K. Kim, and K. M. Huh, Cancer cell-specific photoactivity of pheophorbide A - glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice. Biomaterials 34, 6454 (2013).
104. Y. Zhong, W. Yang, H. Sun, R. Cheng, F. Meng, C. Deng, and Z. Zhong, Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells. Biomacromolecules 14, 3723 (2013).
105. J. Li, M. Huo, J. Wang, J. Zhou, J. M. Mohammad, Y. Zhang, Q. Zhu, A. Y. Waddad, and Q. Zhang, Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials 33, 2310 (2012).
106. J. Liu, W. Huang, Y. Pang, P. Huang, X. Zhu, Y. Zhou, and D. Yan, Molecular self-assembly of a homopolymer: An alternative to fabricate drug-delivery platforms for cancer therapy. Angew. Chem. Int. Ed. 50, 9162 (2011).
107. Z. Liu, J. T. Robinson, X. Sun, and H. Dai, PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 130, 10876 (2008).
108. Q.-Y. Cheng and B.-H. Han, Supramolecular hydrogel based on graphene oxides for controlled release system. J. Nanosci. Nanotechnol. 13, 755 (2013).
109. H. Wen, C. Dong, H. Dong, A. Shen, W. Xia, X. Cai, Y. Song, X. Li, Y. Li, and D. Shi, Engineered redox-responsive PEG detachment mechanism in PEGylated nano-graphene oxide for intracellular drug delivery. Small 8, 760 (2012).
110. W. Gao, R. Langer, and O. C. Farokhzad, Poly(ethylene glycol) with observable shedding. Angew. Chem. Int. Ed. 49, 6567 (2010).
111. K. K. Upadhyay, J. F. L. Meins, A. Misra, P. Voisin, V. Bouchaud, E. Ibarboure, C. Schatz, and S. Lecommandoux, Biomimetic doxorubicin loaded polymersomes from hyaluronan-block-poly(γ-benzyl glutamate) copolymers. Biomacromolecules 10, 2802 (2009).
112. D. E. Discher and A. Eisenberg, Polymer vesicles. Science 297, 967 (2002).
113. M. Muthiah, S. J. Lee, M. Moon, H. J. Lee, W. K. Bae, I. J. Chung, Y. Y. Jeong, and I.-K. Park, Surface tunable polymersomes loaded with magnetic contrast agent and drug for image guided cancer therapy. J. Nanosci. Nanotechnol. 13, 1626 (2013).
114. A. E. Felber, M.-H. Dufresne, and J.-C. Leroux, pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv. Drug Deliv. Rev. 64, 979 (2012).
115. R. Gref, Y. Minamitake, M. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer, Biodegradable long-circulating polymeric nanospheres. Science 263, 1600 (1994).
116. J. Zhang, L. Wu, F. Meng, Z. Wang, C. Deng, H. Liu, and Z. Zhong, pH and reduction dual-bioresponsive polymersomes for efficient intracellular protein delivery. Langmuir 28, 2056 (2011).
117. S. M. Moghimi and J. Szebeni, Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 42, 463 (2003).
118. Y. Shen, E. Jin, B. Zhang, C. J. Murphy, M. Sui, J. Zhao, J. Wang, J. Tang, M. Fan, E. Van Kirk, and W. J. Murdoch, Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J. Am. Chem. Soc. 132, 4259 (2010).
119. V. Pavillard, D. Kherfellah, S. Richard, J. Robert, and D. Montaudon, Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants. Br. J. Cancer. 85, 1077 (2001).
120. S. Cerritelli, D. Velluto, and J. A. Hubbell, PEG-SS-PPS: Reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. Biomacromolecules 8, 1966 (2007).
121. T. Thambi, V. G. Deepagan, H. Ko, D. S. Lee, and J. H. Park, Bioreducible polymersomes for intracellular dual-drug delivery. J. Mater. Chem. 22, 22028 (2012).
122. G. Chabot, Clinical pharmacokinetics of irinotecan. Clin. Pharmacokinet. 33, 245 (1997).
123. J. Wang, X. Sun, W. Mao, W. Sun, J. Tang, M. Sui, Y. Shen, and Z. Gu, Tumor Redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy. Adv. Mater. 25, 3670 (2013).
124. K. H. Min, J.-H. Kim, S. M. Bae, H. Shin, M. S. Kim, S. Park, H. Lee, R.-W. Park, I.-S. Kim, K. Kim, I. C. Kwon, S. Y. Jeong, and D. S. Lee, Tumoral acidic pH-responsive mPEG-Poly(β-amino ester) polymeric micelles for cancer targeting therapy. J. Control Release 144, 259 (2010).
125. G. H. Gao, J. W. Lee, M. K. Nguyen, G. H. Im, J. Yang, H. Heo, P. Jeon, T. G. Park, J. H. Lee, and D. S. Lee, pH-Responsive Polymeric Micelle Based on PEG-Poly(β-amino ester)/(amido amine) as intelligent vehicle for magnetic resonance imaging in detection of cerebral ischemic area. J. Control Release 155, 11 (2011).
126. Y. Bae, S. Fukushima, A. Harada, and K. Kataoka, Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. 42, 4640 (2003).
127. D. Neri and C. T. Supuran, Interfering with pH regulation in tumours as a therapeutic strategy. Nat. Rev. Drug Discov. 10, 767 (2011).
128. R. A. Gatenby and R. J. Gillies, Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891 (2004).
129. I. F. Tannock and D. Rotin, Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49, 4373 (1989).
130. Y. Bae, W.-D. Jang, N. Nishiyama, S. Fukushima, and K. Kataoka, Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol. Biosyst. 1, 242 (2005).
131. S. Binauld and M. H. Stenzel, Acid-degradable polymers for drug delivery: A decade of innovation. Chem. Commun. 49, 2082 (2013).
132. J. Liu, H. Duong, M. R. Whittaker, T. P. Davis, and C. Boyer, Synthesis of functional core, star polymers via RAFT polymerization for drug delivery applications. Macromol. Rapid Commun. 33, 760 (2012).
133. W. Chen, F. Meng, F. Li, S.-J. Ji, and Z. Zhong, pH-responsive biodegradable micelles based on acid-labile polycarbonate hydrophobe: Synthesis and triggered drug release. Biomacromolecules 10, 1727 (2009).
134. Y. Li, H. J. Heo, G. H. Gao, S. W. Kang, C. T. Huynh, M. S. Kim, J. W. Lee, J. H. Lee, and D. S. Lee, Synthesis and characterization of an amphiphilic graft polymer and its potential as a pH-sensitive drug carrier. Polymer 52, 3304 (2011).
135. Y.-Y. Yuan, C.-Q. Mao, X.-J. Du, J.-Z. Du, F. Wang, and J. Wang, Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor. Adv. Mater. 24, 5476 (2012).
136. J. Gu, W.-P. Cheng, J. Liu, S.-Y. Lo, D. Smith, X. Qu, and Z. Yang, pH-triggered reversible "Stealth" polycationic micelles. Biomacromolecules 9, 255 (2007).
137. N. Ma, C. Ma, C. Li, T. Wang, Y. Tang, H. Wang, X. Mou, Z. Chen, and N. He, Influence of nanoparticle shape, size, and surface functionalization on cellular uptake. J. Nanosci. Nanotechnol. 13, 6485 (2013).
138. C. Ding, J. Gu, X. Qu, and Z. Yang, Preparation of multifunctional drug Carrier for tumor-specific uptake and enhanced intracellular delivery through the conjugation of weak acid labile linker. Bioconjugate Chem. 20, 1163 (2009).
139. Y. Jin, L. Song, Y. Su, L. Zhu, Y. Pang, F. Qiu, G. Tong, D. Yan, B. Zhu, and X. Zhu, Oxime linkage: A robust tool for the design of pH-sensitive polymeric drug carriers. Biomacromolecules 12, 3460 (2011).
140. T. Thambi, V. G. Deepagan, C. K. Yoo, and J. H. Park, Synthesis and physicochemical characterization of amphiphilic block copolymers bearing acid-sensitive orthoester linkage as the drug carrier. Polymer 52, 4753 (2011).
141. C. Gao and D. Yan, Hyperbranched polymers: From synthesis to applications. Prog. Polym. Sci. 29, 183 (2004).
142. H. Chen, G. Li, H. Chi, D. Wang, C. Tu, L. Pan, L. Zhu, F. Qiu, F. Guo, and X. Zhu, Alendronate-conjugated amphiphilic hyperbranched polymer based on boltorn H40 and poly(ethylene glycol) for bone-targeted drug delivery. Bioconjugate Chem. 23, 1915 (2012).
143. C. Tu, L. Zhu, F. Qiu, D. Wang, Y. Su, X. Zhu, and D. Yan, Facile PEGylation of boltorn® H40 for pH-responsive drug carriers. Polymer 54, 2020 (2013).
144. F.-Q. Hu, Y.-Y. Zhang, J. You, H. Yuan, and Y.-Z. Du, pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy. Mol. Pharm. 9, 2469 (2012).
145. Y.-L. Li, L. Zhu, Z. Liu, R. Cheng, F. Meng, J.-H. Cui, S.-J. Ji, and Z. Zhong, Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angew. Chem. Int. Ed. 48, 9914 (2009).
146. M. Sivasubramanian, T. Thambi, V. G. Deepagan, G. Saravanakumar, H. Ko, Y. M. Kang, and J. H. Park, Carboxymethyl dextrancyclodextrin conjugate as the carrier of doxorubicin. J. Nanosci. Nanotechnol. 13, 7271 (2013).
147. K. K. Upadhyay, A. K. Mishra, K. Chuttani, A. Kaul, C. Schatz, J.-F. Le Meins, A. Misra, and S. Lecommandoux, The in vivo behavior and antitumor activity of doxorubicin-loaded Poly(γ-benzyl l-glutamate)-block-hyaluronan polymersomes in ehrlich ascites tumor-bearing BalB/c mice. Nanomed.- Nanotechnol. 8, 71 (2012).
148. K. Park, G. Y. Lee, Y.-S. Kim, M. Yu, R.-W. Park, I.-S. Kim, S. Y. Kim, and Y. Byun, Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity. J. Control Release 114, 300 (2006).
149. K. T. Smitha, A. Anitha, T. Furuike, H. Tamura, S. V. Nair, and R. Jayakumar, In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery. Colloids Surf., B 104, 245 (2013).
150. H. Koo, K. H. Min, S. C. Lee, J. H. Park, K. Park, S. Y. Jeong, K. Choi, I. C. Kwon, and K. Kim, Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery. J. Control Release 172, 823 (2013).
151. J. Xie, S. Lee, and X. Chen, Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev. 62, 1064 (2010).
152. L. Deng, G. Wang, J. Ren, B. Zhang, J. Yan, W. Li, and N. M. Khashab, Enzymatically triggered multifunctional delivery system based on hyaluronic acid micelles. RSC Adv. 2, 12909 (2012).
153. K. Y. Choi, K. H. Min, J. H. Na, K. Choi, K. Kim, J. H. Park, I. C. Kwon, and S. Y. Jeong, Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: Synthesis, characterization, and in vivo biodistribution. J. Mater. Chem. 19, 4102 (2009).
154. H. Y. Yoon, H. Koo, K. Y. Choi, S. J. Lee, K. Kim, I. C. Kwon, J. F. Leary, K. Park, S. H. Yuk, J. H. Park, and K. Choi, Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials 33, 3980 (2012).
155. J. F. Lovell, T. W. B. Liu, J. Chen, and G. Zheng, Activatable photosensitizers for imaging and therapy. Chem. Rev. 110, 2839 (2010).
156. R. H. Baughman, A. A. Zakhidov, and W. A. de Heer, Carbon nanotubes-the route toward applications. Science 297, 787 (2002).
157. L. Feng and Z. Liu, Graphene in biomedicine: Opportunities and challenges. Nanomedicine 6, 317 (2011).
158. K. Jiang, L. Ma, J. Wang, and W. Chen, Graphene oxide and reduced graphene oxide: Synthesis, photoluminescence, and biotechnological applications. Rev. Nanosci. Nanotechnol. 2, 171 (2013).
159. I. Bhatnagar, J. Venkatesan, and S.-K. Kim, Polymer functionalized single walled carbon nanotubes mediated drug delivery of gliotoxin in cancer cells. J. Biomed. Nanotechnol. 10, 120 (2014).
160. H. Kim, D. Lee, J. Kim, T.-i. Kim, and W. J. Kim, Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. ACS Nano 7, 6735 (2013).
161. H. Hong, K. Yang, Y. Zhang, J. W. Engle, L. Feng, Y. Yang, T. R. Nayak, S. Goel, J. Bean, C. P. Theuer, T. E. Barnhart, Z. Liu, and W. Cai, In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS Nano 6, 2361 (2012).
162. M. Swierczewska, K. Y. Choi, E. L. Mertz, X. Huang, F. Zhang, L. Zhu, H. Y. Yoon, J. H. Park, A. Bhirde, S. Lee, and X. Chen, A facile, one-step nanocarbon functionalization for biomedical applications. Nano Lett. 12, 3613 (2012).
163. Y. Cho, H. Kim, and Y. Choi, A graphene oxide-photosensitizer complex as an enzyme-activatable theranostic agent. Chem. Commun. 49, 1202 (2013).
164. H. Kim, S. Mun, and Y. Choi, Photosensitizer-conjugated polymeric nanoparticles for redox-responsive fluorescence imaging and photodynamic therapy. J. Mater. Chem. B 1, 429 (2013).
165. D. S. Kwag, K. Park, K. T. Oh, and E. S. Lee, Hyaluronated fullerenes with photoluminescent and antitumoral activity. Chem. Commun. 49, 282 (2013).
166. J. Kopeèek, Polymer-drug conjugates: Origins, progress to date and future directions. Adv. Drug Deliv. Rev. 65, 49 (2013).
167. M. Yokoyama, G. S. Kwon, T. Okano, Y. Sakurai, T. Seto, and K. Kataoka, Preparation of micelle-forming polymer-drug conjugates. Bioconjugate Chem. 3, 295 (1992).
168. J. Sanchis, F. Canal, R. Lucas, and M. J. Vicent, Polymer-drug conjugates for novel molecular targets. Nanomedicine 5, 915 (2010).
169. N. Goodarzi, R. Varshochian, G. Kamalinia, F. Atyabi, and R. Dinarvand, A review of polysaccharide cytotoxic drug conjugates for cancer therapy. Carbohydr. Polym. 92, 1280 (2013).
170. S. Jaracz, J. Chen, L. V. Kuznetsova, and I. Ojima, Recent advances in tumor-targeting anticancer drug conjugates. Bioorg. Med. Chem. 13, 5043 (2005).
171. J. H. Park, S. Kwon, M. Lee, H. Chung, J.-H. Kim, Y.-S. Kim, R.-W. Park, I.-S. Kim, S. Bong Seo, I. C. Kwon, and S. Y. Jeong, Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: In vivo biodistribution and anti-tumor activity. Biomaterials 27, 119 (2006).
172. L. Bildstein, C. Dubernet, and P. Couvreur, Prodrug-based intracellular delivery of anticancer agents. Adv. Drug Deliv. Rev. 63, 3 (2011).
173. G. Pasut and F. M. Veronese, PEG conjugates in clinical development or use as anticancer agents: An overview. Adv. Drug Deliv. Rev. 61, 1177 (2009).
174. M. E. Davis, Design and development of IT-101, a cyclodextrincontaining polymer conjugate of camptothecin. Adv. Drug Deliv. Rev. 61, 1189 (2009).
175. J. Khandare and T. Minko, Polymer-drug conjugates: Progress in polymeric prodrugs. Prog. Polym. Sci. 31, 359 (2006).
176. H. Lee, K. Lee, and T. G. Park, Hyaluronic acid-paclitaxel conjugate micelles: Synthesis, characterization, and antitumor activity. Bioconjugate Chem. 19, 1319 (2008).
177. L. Zhou, R. Cheng, H. Tao, S. Ma, W. Guo, F. Meng, H. Liu, Z. Liu, and Z. Zhong, Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: Synthesis, drug release, and biodistribution in tumor-bearing mice. Biomacromolecules 12, 1460 (2011).
178. B. Chen, R. J. Miller, and P. K. Dhal, Hyaluronic acid-based drug conjugates: State-of-the-art and perspectives. J. Biomed. Nanotechnol. 10, 4 (2014).
179. C. L. Hall, B. Yang, X. Yang, S. Zhang, M. Turley, S. Samuel, L. A. Lange, C. Wang, G. D. Curpen, R. C. Savani, A. H. Greenberg, and E. A. Turley, Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell 82, 19 (1995).
180. B. P. Toole, Hyaluronan: From extracellular glue to pericellular cue. Nat. Rev. Cancer 4, 528 (2004).
181. L. Lapčík, S. De Smedt, J. Demeester, and P. Chabreček, Hyaluronan: Preparation, structure, properties, and applications. Chem. Rev. 98, 2663 (1998).
182. H. Lee, J. B. Kim, S. Y. Park, S.-S. Kim, and H. Kim, Combination effect of paclitaxel and hyaluronic acid on cancer stem-like side population cells. J. Biomed. Nanotechnol. 9, 299 (2013).
183. V. M. Platt and F. C. Szoka, Anticancer therapeutics: Targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol. Pharm. 5, 474 (2008).
184. H. Y. Yoon, H. Koo, K. Y. Choi, I. Chan Kwon, K. Choi, J. H. Park, and K. Kim, Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery. Biomaterials 34, 5273 (2013).
185. S. Misra, P. Heldin, V. C. Hascall, N. K. Karamanos, S. S. Skandalis, R. R. Markwald, and S. Ghatak, Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J. 278, 1429 (2011).
186. Y. Luo and G. D. Prestwich, Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjugate Chem. 10, 755 (1999).
187. D. Coradini, C. Pellizzaro, G. Miglierini, M. G. Daidone, and A. Perbellini, Hyaluronic acid as drug delivery for sodium butyrate: Improvement of the anti-proliferative activity on a breast-cancer cell line. Int. J. Cancer. 81, 411 (1999).
188. D. Coradini, S. Zorzet, R. Rossin, I. Scarlata, C. Pellizzaro, C. Turrin, M. Bello, S. Cantoni, A. Speranza, G. Sava, U. Mazzi, and A. Perbellini, Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-but. Clin. Cancer Res. 10, 4822 (2004).
189. S. Manju and K. Sreenivasan, Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. J. Colloid Interf. Sci. 359, 318 (2011).
190. A. Homma, H. Sato, T. Tamura, A. Okamachi, T. Emura, T. Ishizawa, T. Kato, T. Matsuura, S. Sato, Y. Higuchi, T. Watanabe, H. Kitamura, K. Asanuma, T. Yamazaki, M. Ikemi, H. Kitagawa, T. Morikawa, H. Ikeya, K. Maeda, K. Takahashi, K. Nohmi, N. Izutani, M. Kanda, and R. Suzuki, Synthesis and optimization of hyaluronic acid-methotrexate conjugates to maximize benefit in the treatment of osteoarthritis. Bioorg. Med. Chem. 18, 1062 (2010).
191. J. Varshosaz, Dextran conjugates in drug delivery. Expet. Opin. Drug Deliv. 9, 509 (2012).
192. A. J. van der Vlies, W. Han, H. Uyama, and U. Hasegawa, Dextran acetate-based sponge as cell scaffold for tissue engineering. J. Biomater. Tissue Eng. 4, 28 (2014).
193. D. Nevozhay, R. Budzynska, U. Kanska, M. Jagiello, M. S. Omar, J. Boratynski, and A. Opolski, Antitumor properties and toxicity of dextran-methotrexate conjugates are dependent on the molecular weight of the carrier. Ant. Cancer Res. 26, 1135 (2006).
194. S. Hornig, H. Bunjes, and T. Heinze, Preparation and characterization of nanoparticles based on dextran-drug conjugates. J. Colloid Interf. Sci. 338, 56 (2009).
195. Y. Shiose, H. Kuga, H. Ohki, M. Ikeda, F. Yamashita, and M. Hashida, Systematic research of peptide spacers controlling drug release from macromolecular prodrug system, carboxymethyldextran polyalcohol-peptide-drug conjugates. Bioconjugate Chem. 20, 60 (2008).
196. A. Bernkop-Schnürch and S. Dünnhaupt, Chitosan-based drug delivery systems. Eur. J. Pharm. Biopharm. 81, 463 (2012).
197. J. H. Park, G. Saravanakumar, K. Kim, and I. C. Kwon, Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Deliv. Rev. 62, 28 (2010).
198. M. Sivasubramanian, J.-Y. Lee, K. J. Kim, G. Saravanakumar, Y. M. Kang, and J. H. Park, Cyclodextrin-based nanocomplexes for sustained delivery of human growth hormone. J. Nanosci. Nanotechnol. 13, 7306 (2013).
199. N. S. Rejinold, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, Thermo-responsive chitosan-graft-poly(N-isopropyl acrylamide) co-polymeric nanoparticles for 5-fluorouracil delivery to breast cancer cells in vitro. J. Nanopharm. Drug Delivery 1, 18 (2013).
200. R. Chadha, S. Bhandari, D. Kataria, and S. Gupta, Exploring lecithin/chitosan nanoparticles of ramipril for improved antihypertensive efficacy. J. Nanopharm. Drug Delivery 1, 173 (2013).
201. M. Rajkumar, R. Jayakumar, and H. Freitas, Effects of chitosan derivatives on plant growth and Ni uptake in ricinus communis and helianthus annuus. J. Chitin Chitosan Sci. 1, 65 (2013).
202. N. Mohammed, N. S. Rejinold, S. Mangalathillam, R. Biswas, S. V. Nair, and R. Jayakumar, Fluconazole loaded chitin nanogels as a topical ocular drug delivery agent for corneal fungal infections. J. Biomed. Nanotechnol. 9, 1521 (2013).
203. L. Mazzarino, L. Coche-Guérente, P. L. E. Lemos-Senna, and R. Borsali, On the mucoadhesive properties of chitosan-coated polycaprolactone nanoparticles loaded with curcumin using quartz crystal microbalance with dissipation monitoring. J. Biomed. Nanotechnol. 10, 787 (2014).
204. A. Anitha, S. Uthaman, S. V. Nair, R. Jayakumar, and V.-K. Lakshmanan, Enhanced delivery system of flutamide loaded chitosan-dextran sulphate nanoparticles for prostate cancer. J. Biomed. Nanotechnol. 9, 335 (2013).
205. S. J. Lee, H. Koo, D.-E. Lee, S. Min, S. Lee, X. Chen, Y. Choi, J. F. Leary, K. Park, S. Y. Jeong, I. C. Kwon, K. Kim, and K. Choi, Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials 32, 4021 (2011).
206. Y. Kato, H. Onishi, and Y. Machida, N-succinyl-chitosan as a drug carrier: Water-insoluble and water-soluble conjugates. Biomaterials 25, 907 (2004).
207. Y. Wang, X. Yang, J. Yang, Y. Wang, R. Chen, J. Wu, Y. Liu, and N. Zhang, Self-assembled nanoparticles of methotrexate conjugated O-carboxymethyl chitosan: Preparation, characterization and drug release behavior in vitro. Carbohydr. Polym. 86, 1665 (2011).
208. Y. Qiu, J. Zhu, J. Wang, R. Gong, M. Zheng, and F. Huang, Self-assembled phytosterol-fructose-chitosan nanoparticles as a carrier of anticancer drug. J. Nanosci. Nanotechnol. 13, 5935 (2013).
209. Y. J. Son, J.-S. Jang, Y. W. Cho, H. Chung, R.-W. Park, I. C. Kwon, I.-S. Kim, J. Y. Park, S. B. Seo, C. R. Park, and S. Y. Jeong, Biodistribution and anti-tumor efficacy of doxorubicin loaded glycolchitosan nanoaggregates by EPR effect. J. Control Release 91, 135 (2003).
210. E. Lee, J. Lee, I.-H. Lee, M. Yu, H. Kim, S. Y. Chae, and S. Jon, Conjugated chitosan as a novel platform for oral delivery of paclitaxel. J. Med. Chem. 51, 6442 (2008).
211. A. O. Moughton and R. K. O'Reilly, Noncovalently connected micelles, nanoparticles, and metal-functionalized nanocages using supramolecular self-assembly. J. Am. Chem. Soc. 130, 8714 (2008).
212. Q. Yan, J. Yuan, Z. Cai, Y. Xin, Y. Kang, and Y. Yin, Voltage-responsive vesicles based on orthogonal assembly of two homopolymers. J. Am. Chem. Soc. 132, 9268 (2010).
213. M. Kang and B. Moon, Synthesis of photocleavable Poly(styrene-block- ethylene oxide) and its self-assembly into nanoporous thin films. Macromolecules 42, 455 (2008).
214. J.-M. Schumers, J.-F. Gohy, and C.-A. Fustin, A versatile strategy for the synthesis of block copolymers bearing a photocleavable junction. Polym. Chem. 1, 161 (2010).
215. J. S. Katz, S. Zhong, B. G. Ricart, D. J. Pochan, D. A. Hammer, and J. A. Burdick, Modular synthesis of biodegradable diblock copolymers for designing functional polymersomes. J. Am. Chem. Soc. 132, 3654 (2010).
216. D. Lee, S. Bae, D. Hong, H. Lim, J. H. Yoon, O. Hwang, S. Park, Q. Ke, G. Khang, and P. M. Kang, H2O2-Responsive molecularly engineered polymer nanoparticles as ischemia/reperfusion-targeted nanotherapeutic agents. Sci. Rep. 3, 2233 (2013).
217. J. Geng, M. Li, L. Wu, C. Chen, and X. Qu, Mesoporous silica Nanoparticle-based H2O2 responsive controlled-release system used for alzheimer's disease treatment. Adv. Healthcare Mater. 1, 332 (2012).
218. T. Sun, Y. Jin, R. Qi, S. Peng, and B. Fan, Oxidation responsive mono-cleavable amphiphilic di-block polymer micelles labeled with a single diselenide. Polym. Chem. 4, 4017 (2013).
219. K. E. Broaders, S. Grandhe, and J. M. J. Fréchet, A biocompatible oxidation-triggered carrier polymer with potential in therapeutics. J. Am. Chem. Soc. 133, 756 (2010).
220. C. de Gracia Lux, S. Joshi-Barr, T. Nguyen, E. Mahmoud, E. Schopf, N. Fomina, and A. Almutairi, Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide. J. Am. Chem. Soc. 134, 15758 (2012).
221. M. L. Viger, J. Sankaranarayanan, C. de Gracia Lux, M. Chan, and A. Almutairi, Collective activation of MRI agents via encapsulation and disease-triggered release. J. Am. Chem. Soc. 135, 7847 (2013).